Hindenburg Research founder Nate Anderson, a foe of Carl Icahn and the Adani family, cites the stress of his job as he shuts down the firm.

SYDNEY--Australia's economy continued to create jobs at a strong rate in December, raising doubts about the Reserve Bank of Australia's ability to deliver an interest-rate cut next month. Employment ...

South Korea's central bank unexpectedly stood pat amid lingering pressure to cut its policy rate further to support growth in Asia's fourth-largest economy. The Bank of Korea kept its benchmark ...

Where’d it come out? The average dollar invested in target-date 2050 funds gained nearly 7% per year.

Rio Tinto, the world's No. 2 mining company by market value, on Thursday reported a drop in iron-ore production and shipments from its Australian mines. Fourth-quarter and full-year output and exports ...

Holmes's own position was clear: "The state does none of these things," he wrote - and it should not. This strain of individualism has remained strong in U.S. politics: Individual liberty, personal ...

As floods, storms, wildfires and other catastrophes become increasingly common, the availability and affordability of property insurance has become a high-profile political issue. Politics involve ...

Amber Ugarte and her 7-year-old daughter escaped the Pacific Palisades fire on Jan. 7 with a suitcase full of clothes for each of them; paintings by her grandfather and grandmother; two original ...

My parents, my sister and I - a middle-aged woman - are from overseas, but I've lived in the U.S. for more than half of my life. They went back to live there. I never got along with my mother. I have ...

The Brightline West high-speed rail project linking Southern California to Las Vegas is set to get $2.5 billion from two separate municipal bond sales that will help fund the project's development and ...

Incyte and Syndax Pharmaceutical said the Food and Drug Administration approved their graft disease treatment Niktimvo antibody in nine milligram and 22 milligram vial sizes.

Michael Osso is chief executive officer of the Crohn's & Colitis Foundation. "Eli Lilly Receives FDA Approval for Crohn's Disease Treatment," at 4:40 p.m. ET, and in a subsequent update, incorrectly ...